Kwakkenbos MJ - Search Results

1

Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.

Donkers JM, Zehnder B, van Westen GJP, Kwakkenbos MJ, IJzerman AP, Oude Elferink RPJ, Beuers U, Urban S, van de Graaf SFJ. Donkers JM, et al. Among authors: kwakkenbos mj. Sci Rep. 2017 Nov 10;7(1):15307. doi: 10.1038/s41598-017-15338-0. Sci Rep. 2017. PMID: 29127322 Free PMC article.

2

Stable long-term cultures of self-renewing B cells and their applications.

Kwakkenbos MJ, van Helden PM, Beaumont T, Spits H. Kwakkenbos MJ, et al. Immunol Rev. 2016 Mar;270(1):65-77. doi: 10.1111/imr.12395. Immunol Rev. 2016. PMID: 26864105 Free PMC article. Review.

3

Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence.

Hamann J, Kwakkenbos MJ, de Jong EC, Heus H, Olsen AS, van Lier RA. Hamann J, et al. Among authors: kwakkenbos mj. Eur J Immunol. 2003 May;33(5):1365-71. doi: 10.1002/eji.200323881. Eur J Immunol. 2003. PMID: 12731063 Free article.

4

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming.

Kwakkenbos MJ, Diehl SA, Yasuda E, Bakker AQ, van Geelen CM, Lukens MV, van Bleek GM, Widjojoatmodjo MN, Bogers WM, Mei H, Radbruch A, Scheeren FA, Spits H, Beaumont T. Kwakkenbos MJ, et al. Nat Med. 2010 Jan;16(1):123-8. doi: 10.1038/nm.2071. Epub 2009 Dec 20. Nat Med. 2010. PMID: 20023635 Free PMC article.

5

Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis Patients.

Germar K, Fehres CM, Scherer HU, van Uden N, Pollastro S, Yeremenko N, Hansson M, Kerkman PF, van der Voort EIH, Reed E, Maassen H, Kwakkenbos MJ, Bakker AQ, Klareskog L, Malmström V, de Vries N, Toes REM, Lundberg K, Spits H, Baeten DL. Germar K, et al. Among authors: kwakkenbos mj. Arthritis Rheumatol. 2019 Mar;71(3):340-350. doi: 10.1002/art.40739. Epub 2019 Feb 2. Arthritis Rheumatol. 2019. PMID: 30277007

6

De novo gene mutations in normal human memory B cells.

Slot LM, Wormhoudt TAM, Kwakkenbos MJ, Wagner K, Ballering A, Jongejan A, van Kampen ACM, Guikema JEJ, Bende RJ, van Noesel CJM. Slot LM, et al. Among authors: kwakkenbos mj. Leukemia. 2019 May;33(5):1219-1230. doi: 10.1038/s41375-018-0289-4. Epub 2018 Oct 23. Leukemia. 2019. PMID: 30353030

7

The human EGF-TM7 family member EMR2 is a heterodimeric receptor expressed on myeloid cells.

Kwakkenbos MJ, Chang GW, Lin HH, Pouwels W, de Jong EC, van Lier RA, Gordon S, Hamann J. Kwakkenbos MJ, et al. J Leukoc Biol. 2002 May;71(5):854-62. J Leukoc Biol. 2002. PMID: 11994511

8

An unusual mode of concerted evolution of the EGF-TM7 receptor chimera EMR2.

Kwakkenbos MJ, Matmati M, Madsen O, Pouwels W, Wang Y, Bontrop RE, Heidt PJ, Hoek RM, Hamann J. Kwakkenbos MJ, et al. FASEB J. 2006 Dec;20(14):2582-4. doi: 10.1096/fj.06-6500fje. Epub 2006 Oct 26. FASEB J. 2006. PMID: 17068111

9

EMR1, the human homolog of F4/80, is an eosinophil-specific receptor.

Hamann J, Koning N, Pouwels W, Ulfman LH, van Eijk M, Stacey M, Lin HH, Gordon S, Kwakkenbos MJ. Hamann J, et al. Among authors: kwakkenbos mj. Eur J Immunol. 2007 Oct;37(10):2797-802. doi: 10.1002/eji.200737553. Eur J Immunol. 2007. PMID: 17823986 Free article.

10

The EGF-TM7 family: a postgenomic view.

Kwakkenbos MJ, Kop EN, Stacey M, Matmati M, Gordon S, Lin HH, Hamann J. Kwakkenbos MJ, et al. Immunogenetics. 2004 Jan;55(10):655-66. doi: 10.1007/s00251-003-0625-2. Epub 2003 Nov 27. Immunogenetics. 2004. PMID: 14647991 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page